Virica Awarded NIIMBL Project to Enhance CAR-T Manufacturing

Virica has been selected as a project lead for one of NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals planned projects, which aim to address key opportunities for innovation in biopharmaceutical manufacturing.

NIIMBL is a public-private partnership whose mission is to accelerate biopharmaceutical manufacturing.

Virica, with support from NIIMBL members AstraZeneca and Sartorius Stedim Biotech , aims to increase lentiviral vector production outputs, cut costs, and improve manufacturing efficiency for CAR-T using small-molecule enhancers.

Read NIIMBL’s full press release

The post Virica Awarded NIIMBL Project to Enhance CAR-T Manufacturing appeared first on Virica Biotech .

Full content in Virica Biotech​

    Post source

    Virica Biotech​

    Virica Biotech​

    UNLOCK THE POTENTIAL OF YOUR THERAPEUTIC